Smith & Nephew sells Dermagraft to Advanced BioHealing
This article was originally published in Clinica
Executive Summary
Smith & Nephew (S&N) has sold its Dermagraft business, made up of the two woundcare products Dermagraft and Transcyte, to a privately-held, development-stage company based in New York.